Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Wei Wei, Lei Liu, Zhong-Le Cheng & Bo Hu. (2017) Increased plasma/serum levels of prolactin in multiple sclerosis: a meta-analysis. Postgraduate Medicine 129:6, pages 605-610.
Read now
Read now
Emanuele D’Amico, Aurora Zanghì, Francesco Patti & Mario Zappia. (2017) Palliative care in progressive multiple sclerosis. Expert Review of Neurotherapeutics 17:2, pages 123-127.
Read now
Read now
Justin N. Chee, William H. Gage, William E. McIlroy & Karl F. Zabjek. (2013) Foot placement patterns of female rollator users with multiple sclerosis in the community. Disability and Rehabilitation 35:1, pages 27-35.
Read now
Read now
Andrea Conrad, Michaela Coenen, Henriette SchmalZ, Jürg Kesselring & Alarcos Cieza. (2012) Validation of the Comprehensive ICF Core Set for Multiple Sclerosis from the perspective of occupational therapists. Scandinavian Journal of Occupational Therapy 19:6, pages 468-487.
Read now
Read now
Sheryl R. Haut, E. Jay Bienen & Aaron Miller. (2012) Clinical overview of the seizure risk of dalfampridine
. Expert Opinion on Drug Safety 11:4, pages 651-657.
Read now
Read now
Jeffrey Dunn & Andrew Blight. (2011) Dalfampridine: a brief review of its mechanism of action and efficacy as a treatment to improve walking in patients with multiple sclerosis. Current Medical Research and Opinion 27:7, pages 1415-1423.
Read now
Read now
Pamela A McCombe, Thomas P Gordon & Michael W Jackson. (2009) Bladder dysfunction in multiple sclerosis. Expert Review of Neurotherapeutics 9:3, pages 331-340.
Read now
Read now
Maria Pia Amato, Valentina Zipoli & Emilio Portaccio. (2008) Cognitive changes in multiple sclerosis. Expert Review of Neurotherapeutics 8:10, pages 1585-1596.
Read now
Read now
Articles from other publishers (26)
Abhi Shah, Viraj Panchal, Kashyap Patel, Zainab Alimohamed, Nirja Kaka, Yashendra Sethi & Neil Patel. (2022) Pathogenesis and management of multiple sclerosis revisited. Disease-a-Month, pages 101497.
Crossref
Crossref
Ladan Dayani, Masoud Sadeghi Dinani, Mehdi Aliomrani, Hossein Hashempour, Jaleh Varshosaz & Azade Taheri. (2022) Immunomodulatory effects of cyclotides isolated from Viola odorata in an experimental autoimmune encephalomyelitis animal model of multiple sclerosis. Multiple Sclerosis and Related Disorders 64, pages 103958.
Crossref
Crossref
Zheng Zha, Sisi Liu, Yijiang Liu, Chen Li & Lei Wang. (2022) Potential Utility of Natural Products against Oxidative Stress in Animal Models of Multiple Sclerosis. Antioxidants 11:8, pages 1495.
Crossref
Crossref
Goli Arji, Hossein Rezaeizadeh, Abdolrreza Naser Moghadasi, Mohammad Ali Sahraian, Mehrdad Karimi & Mojtaba Alizadeh. (2022) Complementary and alternative therapies in multiple sclerosis: a systematic literature classification and analysis. Acta Neurologica Belgica 122:2, pages 281-303.
Crossref
Crossref
Marta Sidoryk‐Węgrzynowicz, Beata Dąbrowska‐Bouta, Grzegorz Sulkowski & Lidia Strużyńska. (2021) Nanosystems and exosomes as future approaches in treating multiple sclerosis. European Journal of Neuroscience 54:9, pages 7377-7404.
Crossref
Crossref
Marta Sidoryk-Węgrzynowicz & Lidia Strużyńska. (2021) Astroglial and Microglial Purinergic P2X7 Receptor as a Major Contributor to Neuroinflammation during the Course of Multiple Sclerosis. International Journal of Molecular Sciences 22:16, pages 8404.
Crossref
Crossref
Maria Chountoulesi & Costas Demetzos. (2020) Promising Nanotechnology Approaches in Treatment of Autoimmune Diseases of Central Nervous System. Brain Sciences 10:6, pages 338.
Crossref
Crossref
Rui Pedro Moura & Bruno Sarmento. (2019) Therapeutic Approaches toward Multiple Sclerosis: Where Do We Stand and Where Are We Headed?. Advanced Therapeutics 2:10, pages 1900070.
Crossref
Crossref
Aliza Bitton Ben-Zacharia & Gretchen Mathewson. 2017. Handbook of Relapsing-Remitting Multiple Sclerosis. Handbook of Relapsing-Remitting Multiple Sclerosis
115
134
.
Lauren B. Zapata, Titilope Oduyebo, Maura K. Whiteman, Maria K. Houtchens, Polly A. Marchbanks & Kathryn M. Curtis. (2016) Contraceptive use among women with multiple sclerosis: a systematic review. Contraception 94:6, pages 612-620.
Crossref
Crossref
Deborah Backus. (2016) Increasing Physical Activity and Participation in People With Multiple Sclerosis: A Review. Archives of Physical Medicine and Rehabilitation 97:9, pages S210-S217.
Crossref
Crossref
Alireza Minagar. (2014) Multiple Sclerosis: An Overview of Clinical Features, Pathophysiology, Neuroimaging, and Treatment Options. Colloquium Series on Integrated Systems Physiology: From Molecule to Function 6:4, pages 1-117.
Crossref
Crossref
Setareh Ghahari, Lana S. Khoshbin & Susan J. Forwell. (2014) The Multiple Sclerosis Self-Management Scale. International Journal of MS Care 16:2, pages 61-67.
Crossref
Crossref
T. Iannitti, B. J. Kerr & B. K. Taylor. 2014. Behavioral Neurobiology of Chronic Pain. Behavioral Neurobiology of Chronic Pain
75
97
.
GAIL L. WIDENER. 2013. Neurological Rehabilitation. Neurological Rehabilitation
585
600
.
Danielle Southerst, Mark Labrecque & Silvano Mior. (2012) Pain and pain-related disability in patients with multiple sclerosis: A case series of two patients treated with chiropractic management. Clinical Chiropractic 15:3-4, pages 169-176.
Crossref
Crossref
David R. Cornblath, E. Jay Bienen & Andrew R. Blight. (2012) The Safety Profile of Dalfampridine Extended Release in Multiple Sclerosis Clinical Trials. Clinical Therapeutics 34:5, pages 1056-1069.
Crossref
Crossref
Jeffrey A. Cohen & Alexander Rae-GrantJeffrey A. Cohen & Alexander Rae-Grant. 2012. Handbook of Multiple Sclerosis. Handbook of Multiple Sclerosis
61
81
.
T. Smedal, K-M. Myhr, J. H. Aarseth, B. Gjelsvik, A. G. Beiske, S. B. Glad & L. I. Strand. (2011) The influence of warm versus cold climate on the effect of physiotherapy in multiple sclerosis. Acta Neurologica Scandinavica 124:1, pages 45-52.
Crossref
Crossref
Lawrence M. Samkoff & Andrew D. Goodman. (2011) Symptomatic Management in Multiple Sclerosis. Neurologic Clinics 29:2, pages 449-463.
Crossref
Crossref
Aliza Bitton Ben‐Zacharia. (2011) Therapeutics for Multiple Sclerosis Symptoms. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 78:2, pages 176-191.
Crossref
Crossref
Kathleen Hawker. (2010) PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS. CONTINUUM: Lifelong Learning in Neurology 16, pages 211-225.
Crossref
Crossref
L. Husseini, V.I. Leussink, B.C. Kieseier & H.-P. Hartung. (2010) 4-Aminopyridin (Fampridin)4-Aminopyridine (Fampridine). Der Nervenarzt 81:2, pages 203-211.
Crossref
Crossref
Howard L. Zwibel. (2010) Contribution of impaired mobility and general symptoms to the burden of multiple sclerosis. Advances in Therapy 26:12, pages 1043-1057.
Crossref
Crossref
Lucy Engin & Carolina Pretorius. (2008) Maintaining independence: A therapy pathway of a person with multiple sclerosis. International Journal of Therapy and Rehabilitation 15:12, pages 580-585.
Crossref
Crossref
Jonathan Birns & Maria Fitzpatrick. (2008) Management of spasticity: A brief overview of educational and pharmacological therapies. British Journal of Neuroscience Nursing 4:8, pages 370-373.
Crossref
Crossref